Institute of Oncology of Vojvodina is comprehensive Cancer centre founded in 1965. IOV constitutes a centre of excellence in the field of gynaecologic oncology, bringing together several disciplines, such as Clinic for internal oncology, Clinic for operative oncology, Department for radiotherapy, nuclear medicine, experimental medicine, rehabilitation, epidemiology, Imaging centre, Clinical research unit, Day hospital, Out-patient clinic.
Department of pathology - ongoing projects concerning study of targeted therapy agents in colorectal cancer, breast cancer, pancreas and melanoma. No 200080763 ASPECCT: A study of Panitumumab efficacy and safety compared to Cetuximab in subjects with KRAS Wild –type metastatic colorectal cancer / AMGEN sponsored /. No 20060540 Gemcitabine and AMG479 in metastatic adenocarcinoma of pancreas / AMGEN sponsored
Role within the project
Our Institute has 47 years of experience in comprehensive care in the field of Gyne-oncology, in a country with one of the highest incidence of cervical cancer in Europe. With about 150-200 new cases of cervical cancer per year, we would contribute to faster accrual of patients. Therefore, IOV will participate to the SOPs set up for tumour, serum and PBMC sample collection, the development of written standard sample processing protocols the sample storage, handling, mailing and the set-up of protocol for sequential tumour sampling during chemoradiotherapy (WP4). IOV will be involved in WP2, to register samples into the common eCRF database and to store in liquid nitrogen.IOV will be in charge of sample storage, handling, mailing and the quality control for standard therapy, in particular as regards radiotherapy management in his clinical centre (WP4). IOV will set up central review of main response criteria with relevant imaging (WP4).
Description of key people involved in the project